The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993
Abstract
Background —We sought to determine how much of the recent, substantial fall in coronary heart disease (CHD) mortality rates in New Zealand can be attributed to “evidence-based” medical and surgical treatments and how much can be attributed to cardiovascular risk factor reductions. Methods and Results —A cell-based mortality model was developed and refined. This model combined (1) the published effectiveness of cardiological treatments and risk factor reductions with (2) data on all medical and surgical treatments administered to all CHD patients and (3) trends in population cardiovascular risk factors (principally smoking, cholesterol, and hypertension) from 1982 to 1993 in Auckland, New Zealand (population 996 000). Between 1982 and 1993, CHD mortality rates fell by 23.6%, with 671 fewer CHD deaths than expected from baseline mortality rates in 1982. Forty-six percent of this fall was attributed to treatments (acute myocardial infarction 12%, secondary prevention 12%, hypertension 7%, heart failure 6%, and angina 9%), and 54% was attributed to risk factor reductions (smoking 30%, cholesterol 12%, population blood pressure 8%, and other, unidentified factors 4%). These proportions remained relatively consistent after a robust sensitivity analysis. Conclusions —Approximately half the CHD mortality rate fall in Auckland, New Zealand, was attributed to medical therapies, and approximately half was attributed to reductions in major risk factors. These findings emphasize the importance of a comprehensive strategy that maximizes the population coverage of effective treatments and actively promotes a prevention program, particularly for smoking, diet, and blood pressure reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Self-citationMurray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,109
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
Yusuf, S., Zucker, D., Passamani, E., Peduzzi, P., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K., Killip, T., Norris, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,134
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140 · cited 1×
“(% contribution) (21) (25) (16) (8) (16) (14)”
Kuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., & Ferrario, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11180-2 · Cited by 952
Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors
McGovern, P. G., Pankow, J. S., Shahar, E., Doliszny, K. M., Folsom, A. R., Blackburn, H., & Luepker, R. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341403 · Cited by 699
Hunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
Pocock, S. J., Henderson, R. A., Rickards, A. F., Hampton, J. R., King, S. B., Hamm, C. W., Puel, J., Hueb, W., Goy, J.-J., & Rodriguez, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92897-9 · Cited by 530
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Science of urinary incontinence
Malone-Lee, J. G., Wagg, A., Mundy, A., Fry, C., Lincoln, J., & Naylor, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91344-7 · Cited by 498
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
Vartiainen, E., Puska, P., Pekkanen, J., Toumilehto, J., & Jousilahti, P. (1994) · BMJ · doi:10.1136/bmj.309.6946.23 · Cited by 438
GOLDMAN, L., & COOK, E. F. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-825 · Cited by 381
Capewell, S., Morrison, C. E., & McMurray, J. J. (1999) · Heart · doi:10.1136/hrt.81.4.380 · Cited by 308
Self-citationMant, J., & Hicks, N. (1995) · BMJ · doi:10.1136/bmj.311.7008.793 · Cited by 303
Isles, C. G., Hole, D. J., Hawthorne, V. M., & Lever, A. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)90599-x · Cited by 277
A Critical Evaluation of the Methodology of the Literature on Medication Compliance
Nichol, M. B., Venturini, F., & Sung, J. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18233 · Cited by 114
The impact of high-risk patients on the results of clinical trials
Ioannidis, J. P. A., & Lau, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00149-2 · Cited by 108
Decline in ischaemic heart disease in Iceland and change in risk factor levels.
Sigfússon, N., Sigvaldason, H., Steingrímsdóttir, L., Gudmundsdottir, I. I., Stefansdottir, I., Thorsteinsson, T., & Sigurðsson, G. (1991) · BMJ · doi:10.1136/bmj.302.6789.1371 · Cited by 103
Medical management and the decline in mortality from coronary heart disease.
Beaglehole, R. (1986) · BMJ · doi:10.1136/bmj.292.6512.33 · Cited by 94
Self-citationBots, M. L., & Grobbee, D. E. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300302 · Cited by 76
Evidence-based medicine and treatment choices
Frankel, S., & Smith, G. D. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64334-6 · Cited by 55
Increasing the impact of cardiological treatments. How best to reduce deaths
Capewell, S., Pell, J. P., Morrison, C., & McMurray, J. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1631 · Cited by 40
Self-citationDobson, A. J., Filipiak, B. C., Kuulasmaa, K., Beaglehole, R., Stewart, A. W., Hobbs, M., Parsons, R. W., Keil, U., Greiser, E. M., Korhonen, H. J., et al. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008666 · Cited by 31
Self-citationTrends in Coronary Heart Disease Mortality and Morbidity in Auckland, New Zealand, 1974–1986
JACKSON, R., Stewart, A. W., & Beaglehole, R. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.2.279 · Cited by 17
Self-citationTrends and determinants of blood pressure in Auckland, New Zealand 1982-94.
Trye, P., Jackson, R., Stewart, A. J., Yee, R. L., & Beaglehole, R. (1996) · PubMed · Cited by 11
Self-citation
Cited by
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Self-citationCardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264233010-en · Cited by 1,359
Epidemiology of coronary heart disease and acute coronary syndrome
Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R., & Lucia, A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.06.33 · Cited by 1,203
Cardiovascular Diseases in India: Current Epidemiology and Future Directions
Prabhakaran, D., Jeemon, P., & Roy, A. (2016) · Circulation · doi:10.1161/circulationaha.114.008729 · Cited by 895
Unal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Self-citation
Metadata
- Authors
- Capewell, S., Beaglehole, R., Seddon, M., & McMurray, J.
- Venue
- Circulation
- Published
- 2000-09-26
- Volume
- 102
- Issue
- 13
- Pages
- 1511-1516
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2060347940
- Cited by
- 253
- References
- 34
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.